Article

Study: Wavefront-optimized excimer laser ablation not culprit in night vision disturbances

San Francisco-Wavefront-optimized excimer laser ablation does not appear to induce night vision disturbances-in fact, patients were more likely to report fewer night vision disturbances after the procedure than they did preoperatively, according to Olivia Lee, MD, Emory University, Atlanta.

San Francisco-Wavefront-optimized excimer laser ablation does not appear to induce night vision disturbances-in fact, patients were more likely to report fewer night vision disturbances after the procedure than they did preoperatively, according to Olivia Lee, MD, Emory University, Atlanta.

She and her colleagues performed a retrospective chart review on 346 consecutive eyes in 176 patients who underwent PRK using a proprietary excimer laser (Allegretto Wave, Alcon Laboratories) or LASIK. Thirty percent of the eyes underwent PRK, and 70% underwent LASIK. All procedures were performed by the same surgeon from January 2005 to December 2006.

Patients completed questionnaires both preoperatively and at 3 months postoperatively to assess the incidence of halos and difficulties they encountered driving at night.

At 3 months postoperatively, no eyes experienced severe worsening of halos, 3.5% of eyes experienced moderate worsening of halos, and 6.5% experienced mild worsening of halos.

"Eight percent of patients actually noted some type of improvement," Dr. Lee said.

When analyzing night-driving symptoms, only 2.3% of eyes experienced moderate symptoms, and no eyes experienced severe symptoms postoperatively.

When examining the changes in night-driving disturbances pre- and postoperatively, no eyes experienced severe worsening of symptoms, and 1.2% of eyes experienced moderate worsening. Approximately 75% of eyes experienced no change, and approximately 14% of eyes noted some improvement.

"Overall, there was no difference or correlation in pupil diameter or pre- or postoperative manifest refraction spherical equivalent and changes in halos or difficulty with night driving," Dr. Lee said.

"Night vision complaints rarely occur after wavefront-optimized laser ablation," she concluded. "In our study, patients were more likely to experience no change or have a diminution of symptoms than to have a worsening. Finally, no preoperative factor was correlated with difficulty in night driving."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.